期刊文献+

美国国家医学科研项目管理特点分析 被引量:11

Analysis on the Management Characteristics of the National Medical Science and Technology Programs in United State
下载PDF
导出
摘要 调研分析美国国家主导的医学科研项目管理的特点,从管理的组织架构、战略规划、项目分类管理及流程等方面进行特点分析,归纳其特点包括医学科研管理主体相对独立、集中,专业性强;项目战略规划整体性强,不断调整完善;项目设立覆盖科研产业全链条;项目管理流程规范,管理高效、透明等。结合我国国情,参考国际医学科技计划项目管理特点,应尽快建立集中、高效、专业的项目管理机构或团队进行医学科研项目的专业化管理,在项目设置上充分考虑科研产业链的各个环节,注重转化,进一步规范细化项目管理流程,提高管理效率。 This study analyzed the characteristics of medical research program oriented by the government of U. S. , ran- ging from organizational structure of management, strategic planning, categorical management and the procedure of the pro- gram, etc. The characteristics include: the quality of independence, concentration, high professionalism of medical re- search management bodies, integrity of program strategy planning with constant improvement, program establishment based on coverage of full chain of the research and industry, standardized management procedures, together with efficiency and transparency of management. China is urgent to establish concentrated, efficient, professional organizations for the profes- sional management of medical research program, with the consideration of China~ actual conditions and the reference of in- ternational medical research program management characteristics. Each section of research industrial chain should be con- sidered in program settings. Achievement transformation should be emphasized and program management procedure should be further regulated and specified, so as to promote managerial efficiency.
出处 《科技管理研究》 CSSCI 北大核心 2016年第5期172-175,共4页 Science and Technology Management Research
基金 中华人民共和国国家卫生和计划生育委员会科技教育司课题"我国医学科技计划改革发展战略研究"
关键词 科研管理 医学项目 特点分析 美国国立卫生研究院 research management medical program characteristic analysis NIH
  • 相关文献

参考文献16

  • 1NIH:Federal Funds for Health R&D 2014[EB/OL].[2015-2-3].http://report.nih.gov/Upload Docs/T301%20Fed%20Oblig%20for%20Health%20RD%20by%20Agency%202014.xlsx.
  • 2吕立宁,刘煜.中美医学科研机构的比较与分析[J].中国基础科学,2000(8):31-37. 被引量:3
  • 3NIH:About NIH[EB/OL].(2015-2-2)[2015-2-3].http://www.nih.gov/about/.
  • 4NIH:Executive Summary[EB/OL].[2014-12-1].http://officeofbudget.od.nih.gov/pdfs/FY15/FY2015_Executive_Summary.pdf.
  • 5NIH:Department of Health and Human Services National Institute of Health Overview[EB/OL].[2015-2-6]http://officeofbudget.od.nih.gov/pdfs/FY15/FY2015_Overview.pdf.
  • 6NIH:OER and You:An Introduction to Extramural Research at NIH[EB/OL].(2014-7-2)[2014-12-1].http://grants.nih.gov/grants/intro2oer.htm.
  • 7BOYACK K W,CHEN M C,CHACKO G.Characterization of the Peer Review Network at the Center for Scientific Review,National Institutes of Health.Bornmann L[J].PLo S ONE 2014,9(8):104244.doi:10.1371/journal.pone.0104244.
  • 8NIH:Grant Application Basics[EB/OL].(2014-2-28)[2014-12-1].http://grants.nih.gov/grants/grant_basics.htm.
  • 9NIH:Parent Announcements[EB/OL].(2011-2-10)[2014-12-1].http://grants.nih.gov/grants/guide/parent_announcements.htm.
  • 10NIH:Types of Grant Programs[EB/OL].(2013-9-12)[2014-12-1].http://grants.nih.gov/grants/funding/funding_program.htm.

二级参考文献9

  • 1Collins FS. Reengineering translational science:the time is right[J].Sci Transl Med,2011.90cm17.
  • 2Shaker R,Brady K,Murphy B. Preparedness of the CTSA′s structural and scientific assets to support the mission of the National Center for Advancing Transla-tional Sciences (NCATS)[J].Clin Transl Sci,2012,(02):121-129.
  • 3Micheel CM,Nass SJ,Omenn GS. Evolution of translational omics:lessons learned and the path forward[EB/OL].http://www.iom.edu/Reports/2012/Evolution-of-Translational-Omics.aspx,2012.
  • 4Zerhouni EA. US biomedical research:basic,translational,and clinical sciences[J].Journal of the American Medical Association,2005,(11):1352-1358.
  • 5Zerhouni EA. Clinical research at a crossroads:the NIH roadmap[J].Journal of Investigative Medicine,2006,(04):171-173.
  • 6Califf RM,Berglund L,Principal Investigators of National Institutes of Health Clinical and Translational Science Awards. Linking scientific discovery and better health for the nation:the first three years of the NIH′s Clinical and Translational Science Awards[J].Academic Medicine,2010,(03):457-462.
  • 7Hazard M,Steele S,Wang D. CTSA-IP:a solution to identifying and aggregating intellectual property across the NIH Clinical Translational Science Award (CTSA) consortium of biomedical research institutes[J].Clin Transl Sci,2011,(05):328-1331.
  • 8Barrett JS. The role of quantitative pharmacology in an academic translational research environment[J].AAPS JOURNAL,2008,(01):9-14.
  • 9李正风.基础研究绩效评估的若干问题[J].科学学研究,2002,20(1):67-71. 被引量:46

共引文献111

同被引文献80

引证文献11

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部